IFN-conditioned dendritic cells for the therapy of melanoma: what is missing?

J Immunother. 2011 Oct;34(8):607-609.

Alexandrescu DT, Ichim TE, Riordan NH, Marincola FM, Dasanu CA.

link to full text

A novel method of modifying immune responses by vaccination with lipiodol-siRNA mixtures.

Clinical Use

Anti-angiogenic effect of high doses of ascorbic acid.

Alternative Cancer, Clinical Use, Vitamin C

Allogeneic endometrial regenerative cells: an “Off the shelf solution” for critical limb ischemia?

Clinical Use, MSCs, Stem Cells

Exosomes as a tumor immune escape mechanism: possible therapeutic implications.

Alternative Cancer, Clinical Use

Immune effects of mesenchymal stem cells: implications for Charcot-Marie-Tooth disease.

Clinical Use, MSCs, Stem Cells

Placental mesenchymal and cord blood stem cell therapy for dilated cardiomyopathy.

Clinical Use, MSCs, Stem Cells

Pharmacokinetics of vitamin C: insights into the oral and intravenous administration of ascorbate.

Alternative Cancer, Clinical Use, Vitamin C

Antigen-specific therapy of rheumatoid arthritis.

Clinical Use

Endometrial regenerative cells: a novel stem cell population.

Clinical Use, MSCs, Stem Cells

Stem cell therapy for autism.

Clinical Use, MSCs, Stem Cells

Vitamin C pharmacokinetics after continuous infusion in a patient with prostate cancer.

Alternative Cancer, Clinical Use, Vitamin C

Cord blood in regenerative medicine: do we need immune suppression?

Clinical Use, MSCs, Stem Cells

Therapeutic use of Aldara in chronic myeloid leukemia.

Clinical Use

A pilot clinical study of continuous intravenous ascorbate in terminal cancer patients.

Alternative Cancer, Clinical Use, Vitamin C

Inhibition of intracranial glioma growth by endometrial regenerative cells.

Clinical Use, MSCs, Stem Cells

Orthomolecular oncology review: ascorbic acid and cancer 25 years later.

Alternative Cancer, Clinical Use, Vitamin C

Intravenous vitamin C as a chemotherapy agent: a report on clinical cases.

Alternative Cancer, Clinical Use, Vitamin C

L-ascorbic acid represses constitutive activation of NF-kappaB and COX-2 expression in human acute myeloid leukemia, HL-60.

Alternative Cancer, Clinical Use, Vitamin C

Intravenous ascorbic acid: protocol for its application and use.

Alternative Cancer, Clinical Use, Vitamin C

Effects of a high molecular mass Convolvulus arvensis extract on tumor growth and angiogenesis.

Alternative Cancer, Clinical Use, Supplements

Inhibition of human breast carcinoma cell proliferation by ascorbate and copper.

Alternative Cancer, Clinical Use, Vitamin C

Cytotoxicity of ascorbate, lipoic acid, and other antioxidants in hollow fibre in vitro tumours.

Alternative Cancer, Clinical Use, Vitamin C

Integrative medicine: a paradigm shift in medical education and practice.

Clinical Use

The paradoxical role of lipid peroxidation on carcinogenesis and tumor growth: a commentary.

Alternative Cancer, Clinical Use

Intravenous ascorbate as a tumor cytotoxic chemotherapeutic agent.

Alternative Cancer, Clinical Use, Vitamin C

Improved microplate fluorometer counting of viable tumor and normal cells.

Alternative Cancer, Clinical Use

Comparison of Cost and Potency of Human Mesenchymal Stromal Cell Conditioned Medium Derived from 2- and 3-Dimensional Cultures

Clinical Use, MSCs, Stem Cells, Umbilical Cord

Feasibility of combination allogeneic stem cell therapy for spinal cord injury: a case report.

Clinical Use, MSCs, Stem Cells

Case report of non-healing surgical wound treated with dehydrated human amniotic membrane.

Amnion, Clinical Use, MSCs

Minimally Invasive Autologous Bone Marrow Concentrate Stem Cells in the Treatment of the Chronically Injured Achilles Tendon: A Case Report

Bone Marrow, Clinical Use, Stem Cells

Scalable efficient expansion of mesenchymal stem cells in xeno free media using commercially available reagents.

Bone Marrow, Clinical Use, MSCs

A review of therapeutic effects of mesenchymal stem cell secretions and induction of secretory modification by different culture methods.

Clinical Use, MSCs, Stem Cells

Intravenous ascorbic acid as an adjuvant to interleukin-2 immunotherapy.

Alternative Cancer, Clinical Use, Vitamin C

Clinical experience with intravenous administration of ascorbic acid: achievable levels in blood for different states of inflammation and disease in cancer patients.

Alternative Cancer, Clinical Use

Autologous stromal vascular fraction therapy for rheumatoid arthritis: rationale and clinical safety.

Clinical Use

The king is dead, long live the king: entering a new era of stem cell research and clinical development.

Clinical Use, MSCs, Stem Cells

Targeted gene silencing of TLR4 using liposomal nanoparticles for preventing liver ischemia reperfusion injury.

Clinical Use

Could metabolic syndrome, lipodystrophy, and aging be mesenchymal stem cell exhaustion syndromes?

Aging, Clinical Use, MSCs, Stem Cells

Intravenous ascorbic acid to prevent and treat cancer-associated sepsis?

Alternative Cancer, Clinical Use

Cutaneous sarcoidosis and malignancy: An association between sarcoidosis with skin manifestations and systemic neoplasia.

Clinical Use

Prevention of hyperglycemia-induced myocardial apoptosis by gene silencing of Toll-like receptor-4.

Clinical Use

Clinical feasibility of umbilical cord tissue-derived mesenchymal stem cells in the treatment of multiple sclerosis

Clinical Use, MSCs, Stem Cells, Umbilical Cord

Safety evaluation of allogeneic umbilical cord blood mononuclear cell therapy for degenerative conditions.

Clinical Use, Umbilical Cord

Immunotherapy for melanoma: current status and perspectives.

Alternative Cancer, Clinical Use

Autologous stromal vascular fraction cells: a tool for facilitating tolerance in rheumatic disease.

Adipose (Fat), Clinical Use, Stem Cells

Tumor vaccines in 2010: need for integration.

Alternative Cancer, Clinical Use

Combination stem cell therapy for heart failure.

Clinical Use, Stem Cells

Nutraceutical augmentation of circulating endothelial progenitor cells and hematopoietic stem cells in human subjects.

Clinical Use, MSCs, Stem Cells

The lysosomotropic agent, hydroxychloroquine, delivered in a biodegradable nanoparticle system, overcomes drug resistance of B-chronic lymphocytic leukemia cells in vitro.

Clinical Use

The next generation of burns treatment: intelligent films and matrix, controlled enzymatic debridement, and adult stem cells.

Clinical Use, MSCs, Stem Cells

Circulating endothelial progenitor cells: a new approach to anti-aging medicine?

Aging, Bone Marrow, Clinical Use, MSCs, Stem Cells

Mesenchymal stem cells as anti-inflammatories: implications for treatment of Duchenne muscular dystrophy.

Bone Marrow, Clinical Use, MSCs, Stem Cells

Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosis.

Adipose (Fat), Clinical Use, MSCs, Stem Cells

Feasibility investigation of allogeneic endometrial regenerative cells.

Clinical Use, MSCs, Stem Cells